Dr Dennis Thomas, lead author of HMRI's azithromycin study, said "achieving remission in moderate or severe asthma has huge health and economic benefits". Picture by Jonathan CarrollDr Dennis Thomas, lead author of HMRI's azithromycin study, said "achieving remission in moderate or severe asthma has huge health and economic benefits". Picture by Jonathan CarrollDr Dennis Thomas, lead author of HMRI's azithromycin study, said "achieving remission in moderate or severe asthma has huge health and economic benefits". Picture by Jonathan Carroll
Sign up to read this article
Read news from 100's of titles, curated specifically for you.